TEVA LAUNCHES FINGOLIMOD TEVA
Teva Pharmaceuticals is pleased to announce the launch of Fingolimod Teva, a generic high tech prescription medication indicated for multiple sclerosis. Fingolimod Teva is available in 0.5 mg hard capsules (28 capsules).
For any queries or further information, please contact your local Teva representative.
Further product information is available upon request or from the SmPC available at HPRA.ie.
Adverse events should be reported. Reporting forms and information can be found at www.hpra.ie. Adverse events should also be reported to Teva UK Limited on +44 (0) 207 540 7117 or medinfo@tevauk.com.
Date of preparation: January 2025
Job code: GEN-IE-NP-00126
Read more Product News